Single-cell Omics Market Analysis and Forecast to 2035: Type, End-User, Application, Product, Instruments, Technology

Single-cell Omics Market is anticipated to expand from $2.2 billion in 2025 to $7.4 billion by 2035, growing at a CAGR of approximately 12.3%. The single-cell omics market demonstrates a structured pricing hierarchy based on platform type, assay complexity, throughput, and optional add-ons. Entry-level manual low-throughput scRNA/scDNA-seq preparations cost between US$330 and US$420 per sample, making them suitable for small-scale research. Mid-range commercial platforms, including 10x Genomics Chromium single-cell RNA-seq and Parse Biosciences WT kits, are priced between US$1,260 and US$2,250 per sample or kit, depending on library type and multiplexing capabilities. High-end, multiome assays (snRNA-seq + snATAC-seq) and fixed-cell or immune profiling add-ons range from US$3,200 to US$3,750 per sample, reflecting the complexity of multi-omic measurements.

Reagent and library prep kits for 10x Genomics platforms scale with reaction numbers and throughput: small kits (4 reactions) cost around US$2,310-$6,487, medium kits (16 reactions) around US$23,588, and very high-throughput kits (48 reactions) reach up to US$55,000 per set. Optional chips and dual-index sets add further costs, typically US$557-$1,617 for chips and US$863 for indexing reagents. This structure highlights a clear differentiation between sample-level pricing and batch-scale reagent investment, emphasizing how throughput and assay complexity drive overall costs in the single-cell omics market.

Segment Overview

Based on the type segment, the single-cell omics market is segmented into genomics, transcriptomics, proteomics, and metabolomics. In 2025, genomics accounted for the largest revenue share at USD 953.6 million, driven by its foundational role in detecting DNA-level variation, clonal architecture, and cellular heterogeneity across tissues for disease research and lineage tracing. Transcriptomics is the fastest-growing segment, with innovations in scRNA-seq enabling identification of rare cell types, differentiation trajectories, and dynamic expression patterns in cancer, immunology, and developmental studies. Proteomics and metabolomics are also expanding due to advances in protein quantification and metabolic profiling, contributing to multimodal integration for deeper insights into disease mechanisms and therapeutic responses.

Based on the product segment, the single-cell omics market is segmented into instruments, consumables & reagents, and software & services. In 2025, consumables & reagents accounted for the largest revenue share at USD 1,091.9 million, driven by high-throughput needs in genomic and transcriptomic studies and NIH-funded projects highlighting their critical role in single-cell analysis. Software & services is the fastest-growing segment, fueled by AI integration for multi-omics data analysis, exemplified by Majorbio Cloud's 2024 release of single-omics workflows accelerating bioinformatics discoveries. Instruments also contribute to growth through advanced sequencers, microfluidics, and initiatives like the Single Cell Analysis Program supporting tumor heterogeneity and cellular atlas projects.

Geographical Overview

The global single-cell omics market demonstrates clear regional variation in 2025, with North America emerging as the largest regional market at approximately $967.3 million. Growth is primarily driven by the United States, which benefits from strong research funding, a high concentration of leading genomics companies, and large-scale collaborative initiatives supporting advanced single-cell research. Strategic partnerships, such as industry-clinical laboratory collaborations, are accelerating atlas-scale projects and translational research. Canada further strengthens regional growth through significant government investments aimed at expanding genome sequencing capabilities and enabling personalized, preventive healthcare, while Mexico remains a smaller contributor but shows long-term potential through institutional capacity building and scientific talent development.

Asia-Pacific generates around $488.9 million in 2025 and stands out as the fastest-growing region, supported by China's expanding single-cell research infrastructure, Japan's leadership in advanced single-cell technologies, and India's rapid laboratory development through academic-industry partnerships. Additional momentum comes from rising government investments in biological data platforms in South Korea, expanded omics grant funding in Australia, and precision medicine initiatives in Singapore and Southeast Asia. Europe records about $592.1 million in 2025, driven by large EU-funded genomics programs, strong CRO presence, and cross-border collaborations, while Latin America and the Middle East & Africa show steady growth, led by Brazil and Saudi Arabia, respectively, through national genomics and precision medicine initiatives.

Key Trends and Drivers

Innovations Driving Single-Cell Analysis -

Rising demand for high-throughput single-cell profiling is pushing innovation toward scalable, automated, and multiomic technologies. The launch of 10x Genomics' next-generation Flex assay in October 2025, enabling analysis of up to 100 million cells per week, highlights the shift toward large-volume studies such as CRISPR screens and translational research. Expansion of integrated CRISPR-based workflows, including Illumina's Perturb-seq solution introduced in February 2025, reflects growing interest in multimodal, high-resolution analysis. Meanwhile, cost-efficient tools like Bio-Rad's ddSEQ 3' RNA-Seq Kit and advanced proteomics platforms such as Standard BioTools' CyTOF XT PRO are improving accessibility and accelerating discovery across oncology, immunology, and precision medicine.

Accelerating Automation to Strengthen Single-Cell Omics Workflows -

Automation is a key driver as laboratories seek faster, reproducible, and scalable single-cell workflows. In October 2025, BD and Opentrons launched robotics-enabled solutions supporting million-cell studies, demonstrating strong momentum toward automated platforms. Partnerships such as BD and Hamilton's automation-ready reagents (October 2024) reduce manual errors and improve consistency. Fully automated systems like Singleron and Hamilton's Tensor platform, launched in April 2025, enable high-throughput multiomics sequencing. Advances in cell isolation, including iotaSciences' scPicking Platform, and studies showing 75% reductions in hands-on time further reinforce demand for automated, end-to-end single-cell omics solutions.

Research Scope

• Estimates and forecasts the overall market size across type, end-user, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.\n\nOur research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.